Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panpan Zhou

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Biorxiv : the Preprint Server for Biology|November 19, 2025
Directed evolution of a stem-helix-targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinityPanpan Zhou, Meng Yuan, Yuexiu Zhang, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
A broad and potent neutralization epitope in SARS-related coronavirusesMeng Yuan, Xueyong Zhu, Wan-Ting He, et al.
JCI Insight|June 15, 2017
Delineating antibody recognition against Zika virus during natural infectionLei Yu, Ruoke Wang, Fei Gao, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2022
A broad and potent neutralization epitope in SARS-related coronavirusesMeng Yuan, Xueyong Zhu, Wan-Ting He, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infectionPanpan Zhou, Meng Yuan, Ge Song, et al.
Science Translational Medicine|February 8, 2022
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infectionPanpan Zhou, Meng Yuan, Ge Song, et al.
Iscience|August 16, 2022
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathwaysFangzhu Zhao, Celina Keating, Gabriel Ozorowski, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic driftGe Song, Meng Yuan, Hejun Liu, et al.
Cell Reports|July 8, 2025
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic driftGe Song, Meng Yuan, Hejun Liu, et al.
Nature Immunology|June 2, 2022
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like virusesWan-Ting He, Rami Musharrafieh, Ge Song, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|November 19, 2025
Directed evolution of a stem-helix-targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinityPanpan Zhou, Meng Yuan, Yuexiu Zhang, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
A broad and potent neutralization epitope in SARS-related coronavirusesMeng Yuan, Xueyong Zhu, Wan-Ting He, et al.
JCI Insight|June 15, 2017
Delineating antibody recognition against Zika virus during natural infectionLei Yu, Ruoke Wang, Fei Gao, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2022
A broad and potent neutralization epitope in SARS-related coronavirusesMeng Yuan, Xueyong Zhu, Wan-Ting He, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infectionPanpan Zhou, Meng Yuan, Ge Song, et al.
Science Translational Medicine|February 8, 2022
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infectionPanpan Zhou, Meng Yuan, Ge Song, et al.
Iscience|August 16, 2022
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathwaysFangzhu Zhao, Celina Keating, Gabriel Ozorowski, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic driftGe Song, Meng Yuan, Hejun Liu, et al.
Cell Reports|July 8, 2025
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic driftGe Song, Meng Yuan, Hejun Liu, et al.
Nature Immunology|June 2, 2022
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like virusesWan-Ting He, Rami Musharrafieh, Ge Song, et al.
Pageof 13